Ambrx Biopharma Inc. AMAM
28.00 +28.00
Day range unavailable
52-week range unavailable
Revenue & Expenses
Latest period ending Dec 31, 2022 · select a line to chart its full history
Income statement
| Fiscal year | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 | FY 2020 Dec 31, 2020 | FY 2019 Dec 31, 2019 |
|---|---|---|---|---|
| 7.40M | 7.46M | 13.67M | 10.31M | |
| 7.40M | 7.46M | 13.67M | 10.31M | |
| -76.40M | -64.42M | -13.12M | -22.47M | |
| -78.00M | -68.08M | -16.54M | -20.06M | |
| -2.03 | -3.36 | -0.98 | -1.05 |
Balance sheet
| Fiscal year | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 | FY 2020 Dec 31, 2020 | FY 2019 Dec 31, 2019 |
|---|---|---|---|---|
| 56.44M | 170.91M | 91.28M | 16.26M | |
| 146.98M | 229.02M | 134.02M | 61.73M | |
| 29.13M | 39.05M | 19.14M | 25.74M | |
| 11.98M | 13.13M | 3.19M | 4.65M | |
| 117.85M | 189.97M | -139.43M | 33.42M |
Cash flow
| Fiscal year | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 | FY 2020 Dec 31, 2020 | FY 2019 Dec 31, 2019 |
|---|---|---|---|---|
| -68.67M | -44.64M | -20.58M | -2.77M | |
| -46.72M | -3.21M | -252.00K | -48.00K | |
| 928.00K | 127.43M | 95.68M | 0 | |
| -1.05M | -1.96M | -252.00K | -48.00K | |
| -114.47M | 79.63M | 75.02M | -2.85M |